Nasopharyngeal carcinoma future or investigational therapies
|
Nasopharyngeal carcinoma Microchapters |
|
Differentiating Nasopharyngeal carcinoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Nasopharyngeal carcinoma future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Nasopharyngeal carcinoma future or investigational therapies |
|
FDA on Nasopharyngeal carcinoma future or investigational therapies |
|
CDC on Nasopharyngeal carcinoma future or investigational therapies |
|
Nasopharyngeal carcinoma future or investigational therapies in the news |
|
Blogs on Nasopharyngeal carcinoma future or investigational therapies |
|
Risk calculators and risk factors for Nasopharyngeal carcinoma future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2]
Overview
Treatments under clinical evaluation for patients with nasopharyngeal cancer include dose escalation with new radiation therapy techniques such as stereotactic radiation therapy boost and brachytherapy.[1]
Future Treatment
Treatments under clinical evaluation for patients with nasopharyngeal cancer include the following:[1]
- Dose escalation with new radiation therapy techniques such as stereotactic radiation therapy boost
- Brachytherapy
References
- ↑ 1.0 1.1 Tate DJ, Adler JR, Chang SD, Marquez S, Eulau SM, Fee WE; et al. (1999). "Stereotactic radiosurgical boost following radiotherapy in primary nasopharyngeal carcinoma: impact on local control". Int J Radiat Oncol Biol Phys. 45 (4): 915–21. PMID 10571198.